Advertisement

Comparison of Prognostic Significance of Amino-Terminal Pro-Brain Natriuretic Peptide Versus Blood Urea Nitrogen for Predicting Events in Patients Hospitalized for Heart Failure

      N-terminal pro-brain natriuretic peptide (NT–pro-BNP) and blood urea nitrogen (BUN) predict outcomes in patients with heart failure (HF). However, it is unknown whether NT–pro-BNP is a better prognostic marker than BUN in patients hospitalized with HF. Chart reviews were performed on 257 consecutively hospitalized patients with HF whose NT–pro-BNP levels were drawn at the time of admission. The ability of NT–pro-BNP and BUN to predict the primary end point (death or readmission <30 days after discharge) was determined. Seventy-three patients (28%) reached the primary end point. Patients who reached the primary end point had significantly higher NT–pro-BNP and BUN levels. On multivariate regression analysis, the predictive values of BUN and NT–pro-BNP were very similar: the hazard ratio for NT–pro-BNP greater than the median was 1.81 (p = 0.044), and the hazard ratio for BUN greater than the median was 1.83 (p = 0.039). Analysis of the associations between NT–pro-BNP, BUN, and 30-day death or readmission as end points showed that BUN is a better predictor of outcomes (hazard ratio 3.15, p = 0.012) than NT–pro-BNP (hazard ratio 1.44, p = 0.399). In conclusion, in patients admitted to hospitals with HF, BUN is at least an equal prognosticator of HF rehospitalization or death as NT–pro-BNP. BUN outperforms NT–pro-BNP in predicting mortality in patients with advanced HF. If admitting physicians are confident that the diagnosis of HF is correct, then admission NT–pro-BNP adds little to clinical management.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Doust J.A.
        • Pietrzak E.
        • Dobson A.
        • Glasziou P.P.
        How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review.
        BMJ. 2005; 330: 625-633
        • Bayes-Genis A.
        • Lopez L.
        • Zapico E.
        • Cotes C.
        • Santalo M.
        • Ordonez-Llanos J.
        • Cinca J.
        NT-ProBNP reduction percentage during admission for acutely decompensated heart failure predicts long-term cardiovascular mortality.
        J Cardiac Fail. 2005; 11: S3-S8
        • Heywood J.T.
        • Elatre W.
        • Pai R.G.
        • Fabbri S.
        • Huiskes B.
        Simple clinical criteria to determine the prognosis of heart failure.
        J Cardiovasc Pharmacol Ther. 2005; 10: 173-180
        • Aronson D.
        • Mittleman M.A.
        • Burger A.J.
        Elevated blood urea nitrogen level as a predictor of mortality in patients admitted for decompensated heart failure.
        Am J Med. 2004; 116: 466-473
        • Tsutamoto T.
        • Wada A.
        • Sakai H.
        • Ishikawa C.
        • Tanaka T.
        • Hayashi M.
        • Fujii M.
        • Yamamoto T.
        • Dohke T.
        • Ohnishi M.
        • et al.
        Relationship between renal function and plasma brain natriuretic peptide in patients with heart failure.
        J Am Coll Cardiol. 2006; 47: 583-586
        • Logeart D.
        • Thabut G.
        • Jourdain P.
        • Chavelas C.
        • Beyne P.
        • Beauvais F.
        • Bouvier E.
        • Cohen Solal A.
        Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure.
        J Am Coll Cardiol. 2004; 43: 635-641
        • Feola M.
        • Aspromonte N.
        • Canali C.
        • Ceci V.
        • Giovinazzo P.
        • Milani L.
        • Quarta G.
        • Ricci R.
        • Scardovi A.B.
        • Uslenghi E.
        • Valle R.
        Prognostic value of plasma brain natriuretic peptide, urea nitrogen, and creatinine in outpatients >70 years of age with heart failure.
        Am J Cardiol. 2005; 96: 705-709
        • Januzzi Jr, J.L.
        • Sakhuja R.
        • O’Donoghue M.
        • Baggish A.L.
        • Anwaruddin S.
        • Chae C.U.
        • Cameron R.
        • Krauser D.G.
        • Tung R.
        • Camargo Jr, C.A.
        • Lloyd-Jones D.M.
        Utility of amino-terminal pro-brain natriuretic peptide testing for prediction of 1-year mortality in patients with dyspnea treated in the emergency department.
        Arch Int Med. 2006; 166: 315-320